Your browser doesn't support javascript.
loading
Target Prices Influence Hospital Participation And Shared Savings In Medicare Bundled Payment Program.
Berlin, Nicholas L; Gulseren, Baris; Nuliyalu, Ushapoorna; Ryan, Andrew M.
Afiliação
  • Berlin NL; Nicholas L. Berlin is a National Clinician Scholar in the Institute for Healthcare Policy and Innovation at the University of Michigan, in Ann Arbor, Michigan.
  • Gulseren B; Baris Gulseren is a health policy analyst in the Institute for Healthcare Policy and Innovation, University of Michigan.
  • Nuliyalu U; Ushapoorna Nuliyalu is a statistician in the Center for Healthcare Outcomes and Policy, Institute for Healthcare Policy and Innovation, University of Michigan.
  • Ryan AM; Andrew M. Ryan (amryan@umich.edu) is the UnitedHealthcare Professor of Health Care Management, Department of Health Management and Policy, University of Michigan School of Public Health, and director of the Center for Evaluating Health Reform, University of Michigan.
Health Aff (Millwood) ; 39(9): 1479-1485, 2020 09.
Article em En | MEDLINE | ID: mdl-32897775
ABSTRACT
To reduce episode spending for twenty-nine predefined clinical conditions, the Centers for Medicare and Medicaid Services (CMS) implemented the voluntary Bundled Payments for Care Improvement (BPCI) Advanced Model program in 2018. Under this program, hospitals gain or lose revenue depending on their episode spending relative to target prices set by CMS. The relationship between target prices and hospital participation in BPCI Advanced is unknown, as are the financial implications for CMS. Using Medicare claims, we estimate that each $1,000 increase in target prices increased the probability of participation by 0.78 percentage points across all episodes. We then used Medicare claims before the start of BPCI Advanced to evaluate mean reversion, or the tendency for episode spending at individual hospitals to move closer to average episode spending over time, especially for hospitals having higher target prices. Hospitals with spending that was 10 percent more than target prices at baseline could expect spending to decline by 7.43 percent in the performance period, hospitals with spending that was 20 percent more saw spending decline by 9.80 percent, and hospitals with spending that was 30 percent more saw spending decline by 11.93 percent. Our findings suggest that CMS will end up paying substantial bonuses to hospitals that resulted from mean reversion rather than from meaningful reductions in costs.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medicare / Pacotes de Assistência ao Paciente Tipo de estudo: Health_economic_evaluation / Prognostic_studies Limite: Aged / Humans País/Região como assunto: America do norte Idioma: En Revista: Health Aff (Millwood) Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medicare / Pacotes de Assistência ao Paciente Tipo de estudo: Health_economic_evaluation / Prognostic_studies Limite: Aged / Humans País/Região como assunto: America do norte Idioma: En Revista: Health Aff (Millwood) Ano de publicação: 2020 Tipo de documento: Article